Company
Facet Technologies
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
5
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Facet Technologies, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Facet Technologies.
Latest FDA decisions
K232912 · Decided Jan 25, 2024 · 128 days after receipt
Device type: Multiple Use Blood Lancet For Single Patient Use Only (QRL) · General & Plastic Surgery
K223370 · Decided Feb 13, 2023 · 101 days after receipt
Device type: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (FMK) · General & Plastic Surgery
K223099 · Decided Nov 28, 2022 · 59 days after receipt
Device type: Multiple Use Blood Lancet For Single Patient Use Only (QRL) · General & Plastic Surgery
2 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Lancet Blood Volume Comparison StudyCompleted
NCT01916096 · 180 participants · Start Feb 2012 · Primary completion Feb 2012
Device: Delica Device · For: Diabetes
Sites: Kennesaw, Georgia
NCT01914302 · 64 participants · Start Jul 2013 · Primary completion Jul 2013
Device: Delica Lancing Device; Flash Lancing Device and 6 more · For: Diabetes
Sites: Kennesaw, Georgia
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0174-2009 · Started Jul 18, 2008 · Posted by FDA Oct 27, 2008
Reason given: The Alternate Site Cap was not included in the package as indicated on the labeling.
Cause as FDA categorized it: Error in labeling · Device type: Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (FMK)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.